Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
1.030
+0.020 (1.98%)
At close: Nov 4, 2024, 4:00 PM
1.070
+0.040 (3.88%)
After-hours: Nov 4, 2024, 5:34 PM EST
Clearside Biomedical Employees
Clearside Biomedical had 30 employees as of December 31, 2023. The number of employees decreased by 6 or -16.67% compared to the previous year.
Employees
30
Change (1Y)
-6
Growth (1Y)
-16.67%
Revenue / Employee
$250,800
Profits / Employee
-$1,115,200
Market Cap
76.99M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Metagenomi | 236 |
Xtant Medical Holdings | 215 |
Rani Therapeutics Holdings | 140 |
RAPT Therapeutics | 131 |
Adlai Nortye | 127 |
ALX Oncology Holdings | 72 |
IO Biotech | 68 |
electroCore | 68 |
CLSD News
- 16 hours ago - Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors - GlobeNewsWire
- 4 days ago - Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024 - GlobeNewsWire
- 13 days ago - Clearside Biomedical's Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting - GlobeNewsWire
- 26 days ago - Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes - GlobeNewsWire
- 2 months ago - Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD - GlobeNewsWire
- 3 months ago - Clearside Biomedical to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference - GlobeNewsWire
- 3 months ago - Clearside Biomedical to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024 - GlobeNewsWire
- 3 months ago - Clearside Biomedical, Inc. (CLSD) Suprachoroidal Space Drug Delivery (Transcript) - Seeking Alpha